{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:02:54Z","timestamp":1759104174865,"version":"3.44.0"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.imlet.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T17:41:14Z","timestamp":1632159674000},"page":"9-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Recent preclinical study offers a promising clue: Role of regulatory T cells as biomarkers in migraine"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8770-4083","authenticated-orcid":false,"given":"Murugesan","family":"Arumugam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4779-3290","authenticated-orcid":false,"given":"S.","family":"Sugin Lal Jabaris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2021.09.004_bib0001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.npbr.2018.11.003","article-title":"Rethinking of the concepts: migraine is an autoimmune disease?","volume":"31","author":"Arumugam","year":"2019","journal-title":"Neurol. Psychiatry Brain Res."},{"key":"10.1016\/j.imlet.2021.09.004_bib0002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s10194-020-01211-5","article-title":"Immunogenicity of biologic therapies for migraine: a review of current evidence","volume":"22","author":"Joshua","year":"2021","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.imlet.2021.09.004_bib0003","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12967-020-02681-6","article-title":"Anti-migraine agents from an immunological point of view","volume":"19","author":"Mushref","year":"2021","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.imlet.2021.09.004_bib0004","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/head.14153","article-title":"The American headache society consensus statement: update on integrating new migraine treatments into clinical practice","volume":"61","author":"Jessica","year":"2021","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.imlet.2021.09.004_bib0005","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s10194-018-0883-x","article-title":"Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal","volume":"19","author":"Mi Ji","year":"2018","journal-title":"J. Headache Pain"},{"issue":"10283","key":"10.1016\/j.imlet.2021.09.004_bib0006","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0140-6736(20)32162-0","article-title":"Migraine: disease characterisation, biomarkers, and precision medicine","volume":"397","author":"Messoud","year":"2021","journal-title":"Lancet"},{"issue":"12277","key":"10.1016\/j.imlet.2021.09.004_bib0007","article-title":"The role of the immune system and the biomarker CD3\u00a0+\u00a0CD4\u00a0+\u00a0CD45RA- CD62L- in the pathophysiology of migraine","volume":"10","author":"Pavelek","year":"2020","journal-title":"Sci. Rep."},{"issue":"290","key":"10.1016\/j.imlet.2021.09.004_bib0008","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2015.11.015","article-title":"Reduction of CD4(+) CD25(+) regulatory T-cells in migraine: is migraine an autoimmune disorder?","volume":"15","author":"Arumugam","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"8","key":"10.1016\/j.imlet.2021.09.004_bib0009","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/01616412.2021.1915077","article-title":"Reduced regulatory T lymphocytes in migraine patients","volume":"43","author":"Faraji","year":"2021","journal-title":"Neurol. Res."},{"issue":"12","key":"10.1016\/j.imlet.2021.09.004_bib0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3389\/fncel.2018.00326","article-title":"Purinergic profiling of regulatory T-cells in patients with episodic migraine","volume":"25","author":"Nurkhametova","year":"2018","journal-title":"Front. Cell Neurosci."},{"issue":"6","key":"10.1016\/j.imlet.2021.09.004_bib0011","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/j.pain.0000000000001818","article-title":"Low-dose interleukin-2 reverses behavioral sensitization in multiple mouse models of headache disorders","volume":"161","author":"Zhang","year":"2020","journal-title":"Pain"},{"issue":"12","key":"10.1016\/j.imlet.2021.09.004_bib0012","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.it.2012.07.007","article-title":"Application of IL-2 therapy to target T regulatory cell function","volume":"33","author":"Ethan","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.imlet.2021.09.004_bib0013","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijsu.2015.07.710","article-title":"Increased incidence of migraine in women correlates with obstetrics and gynaecological surgical procedures","author":"Arumugam","year":"2015","journal-title":"Int. J. Surg."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247821001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:39:47Z","timestamp":1759045187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247821001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":13,"alternative-id":["S0165247821001450"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.09.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"type":"print","value":"0165-2478"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent preclinical study offers a promising clue: Role of regulatory T cells as biomarkers in migraine","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}